Le Lézard
Classified in: Science and technology
Subject: PDT

AdvoLogix: Eliminating Silos with Spend and Matter Management


SUGAR LAND, Texas, May 7, 2024 /PRNewswire/ -- AdvoLogix®, a leading innovator in cloud-based legal management, is revolutionizing how legal teams work. AdvoLogix's all-encompassing platform, built entirely on Salesforce, seamlessly integrates Spend Management, Matter Management, Document Management, and finely-tuned legal-specific AI. This unified approach eliminates the inefficiencies of disconnected systems, empowering legal professionals with unparalleled efficiency, simplified operations, and access to valuable business intelligence.

"Our integrated solution eliminates the need for juggling multiple systems," says Jonathan Reed, CEO of AdvoLogix.

Unlock Legal Agility

Legal teams are often bogged down by fragmented systems, wasting time switching between applications and struggling for a holistic view. At CLOC Global Institute 2024, AdvoLogix stands out. It's the only platform developed directly on Salesforce that offers such deep, integrated functionality in one platform, specifically designed for corporate and outside counsel.

Seamless Control & Insight

"Our integrated solution eliminates the need for juggling multiple systems," says Jonathan Reed, CEO of AdvoLogix. "It provides a unified solution that manages every aspect of legal operations from a single interface. Building on Salesforce ensures complete control of functionality and seamless interoperability with existing tools like Outlook, Google Apps, and document management systems." This approach simplifies workflows, enhances user experience, and guarantees consistent data integrity ? all while empowering data-driven decision making through valuable business intelligence.

Unified Spend and Matter Management with AI-Driven Insights

Legal teams now have a powerful tool to optimize spend and make data-driven decisions. AdvoLogix seamlessly integrates Spend Management with Matter Management, creating a unified platform for cost control. This combination allows legal professionals to track and analyze legal spend in real-time, identify areas for optimization, and make informed budgeting decisions. Our finely-tuned legal AI extracts crucial insights from spend data to identify trends, predict future costs, and negotiate better rates with vendors. This empowers legal teams to achieve unparalleled control over their legal spend.

Experience AdvoLogix at CLOC Global Institute

Discover how AdvoLogix can break down your legal silos and unlock valuable business intelligence. Visit AdvoLogix in Booth #305 at CLOC Global Institute.

About AdvoLogix

Founded in 2006, AdvoLogix is a premier provider of cloud-based legal solutions, helping corporate counsel and law firms streamline operations, reduce costs, and improve productivity with an all-encompassing Salesforce-native platform.

Media Contact:
AdvoLogix Marketing Team
Email: [email protected]

SOURCE AdvoLogix


These press releases may also interest you

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: